The Prescription Project Applauds Legislation Requiring Disclosure of Physician-Industry Relationships

Navigate to:

The Prescription Project Applauds Legislation Requiring Disclosure of Physician-Industry Relationships

Boston, Massachusetts - The following is the statement of Robert Restuccia, Executive Director for The Prescription Project, regarding the revised Physician Payments Sunshine Act filed today.

“We commend Senators Kohl and Grassley for their leadership in crafting a bill to create much needed transparency around the financial relationships between physicians and the drug and medical devices industries.

“Pharmaceuticals and medical devices clearly play a critical role in patient care. However, aggressive industry marketing of new drugs and devices to doctors through undisclosed gifts, consulting payments, speaking fees, classes, and meals can inappropriately influence medical decisions and create conflicts of interest.

Congressional investigations and media reports have highlighted the potential for marketing to exert undue influence on prescribing. By requiring full disclosure of gifts and financial relationships and making that information easily accessible to the public, the Sunshine Act ensures that government and individual citizens alike can make informed decisions about prescription drug and medical device use.

“The Physician Payments Sunshine Act includes many provisions that are essential to a strong and comprehensive federal disclosure law, including:

  • a $100 annual aggregate reporting threshold for gifts and payments
  • a requirement that all pharmaceutical, biotech and medical device companies and their subsidiaries disclose gifts and payments
  • a mandate that state-level data be available to state governments for analysis

“This bill would limit the ability of states to pursue similar initiatives, making it essential that any federal legislation is at least as comprehensive as any existing state measure.”

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.